155 related articles for article (PubMed ID: 37798723)
1. Ex-vivo RNA expression analysis of vaccine candidate genes in COPD sputum samples.
Brettoni C; Muzzi A; Rondini S; Weynants V; Rossi Paccani S
Respir Res; 2023 Oct; 24(1):243. PubMed ID: 37798723
[TBL] [Abstract][Full Text] [Related]
2. Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial.
Andreas S; Testa M; Boyer L; Brusselle G; Janssens W; Kerwin E; Papi A; Pek B; Puente-Maestu L; Saralaya D; Watz H; Wilkinson TMA; Casula D; Di Maro G; Lattanzi M; Moraschini L; Schoonbroodt S; Tasciotti A; Arora AK; Maltais F;
Lancet Respir Med; 2022 May; 10(5):435-446. PubMed ID: 35026180
[TBL] [Abstract][Full Text] [Related]
3. Sputum sample positivity for Haemophilus influenzae or Moraxella catarrhalis in acute exacerbations of chronic obstructive pulmonary disease: evaluation of association with positivity at earlier stable disease timepoints.
Malvisi L; Taddei L; Yarraguntla A; Wilkinson TMA; Arora AK;
Respir Res; 2021 Feb; 22(1):67. PubMed ID: 33627095
[TBL] [Abstract][Full Text] [Related]
4. Long-term immunogenicity and safety of a non-typeable
De Smedt P; Leroux-Roels G; Vandermeulen C; Tasciotti A; Di Maro G; Dozot M; Casula D; Annaratone M; Riccucci D; Arora AK
Vaccine X; 2021 Dec; 9():100124. PubMed ID: 34820619
[TBL] [Abstract][Full Text] [Related]
5. A detailed analysis of possible efficacy signals of NTHi-Mcat vaccine against severe COPD exacerbations in a previously reported randomised phase 2b trial.
Arora AK; Chinsky K; Keller C; Mayers I; Pascual-Guardia S; Vera MP; Lambert C; Lombardi S; Rondini S; Tian S; Ulloa-Montoya F; Moraschini L; Casula D;
Vaccine; 2022 Sep; 40(41):5924-5932. PubMed ID: 36068109
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study.
Galgani I; Annaratone M; Casula D; Di Maro G; Janssens M; Tasciotti A; Schwarz T; Ferguson M; Arora AK
Respir Res; 2022 May; 23(1):114. PubMed ID: 35509077
[TBL] [Abstract][Full Text] [Related]
7. Lung mucosal immunity to NTHi vaccine antigens: Antibodies in sputum of chronic obstructive pulmonary disease patients.
Baffetta F; Buonsanti C; Moraschini L; Aprea S; Canè M; Lombardi S; Contorni M; Rondini S; Arora AK; Bardelli M; Finco O; Serruto D; Paccani SR
Hum Vaccin Immunother; 2024 Dec; 20(1):2343544. PubMed ID: 38655676
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine.
Van Damme P; Leroux-Roels G; Vandermeulen C; De Ryck I; Tasciotti A; Dozot M; Moraschini L; Testa M; Arora AK
Vaccine; 2019 May; 37(23):3113-3122. PubMed ID: 31029515
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of the non-typable
Galgani I; Põder A; Jõgi R; Anttila VJ; Milleri S; Borobia AM; Launay O; Testa M; Casula D; Grassano L; Tasciotti A; Dozot M; Arora AK
Hum Vaccin Immunother; 2023 Dec; 19(1):2187194. PubMed ID: 36974988
[TBL] [Abstract][Full Text] [Related]
10. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
[TBL] [Abstract][Full Text] [Related]
11. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010010. PubMed ID: 28626902
[TBL] [Abstract][Full Text] [Related]
12. Impact of bacterial strain acquisition in the lung of patients with COPD: the AERIS study.
Malvisi L; Yarraguntla A; Mortier MC; Osman K; Cleary DW; Sente B; Pascal TG; Weynants V; Clarke SC; Taddei L; Wilkinson TMA; Devaster JM; Devos N;
Infect Dis (Lond); 2022 Nov; 54(11):784-793. PubMed ID: 35794793
[TBL] [Abstract][Full Text] [Related]
13. Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial.
Wilkinson TMA; Schembri S; Brightling C; Bakerly ND; Lewis K; MacNee W; Rombo L; Hedner J; Allen M; Walker PP; De Ryck I; Tasciotti A; Casula D; Moris P; Testa M; Arora AK
Vaccine; 2019 Sep; 37(41):6102-6111. PubMed ID: 31447126
[TBL] [Abstract][Full Text] [Related]
14. A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD.
Wilkinson TMA; Aris E; Bourne S; Clarke SC; Peeters M; Pascal TG; Schoonbroodt S; Tuck AC; Kim V; Ostridge K; Staples KJ; Williams N; Williams A; Wootton S; Devaster JM;
Thorax; 2017 Oct; 72(10):919-927. PubMed ID: 28432209
[TBL] [Abstract][Full Text] [Related]
15. Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD.
Parameswaran GI; Sethi S; Murphy TF
Chest; 2011 Sep; 140(3):611-617. PubMed ID: 21349930
[TBL] [Abstract][Full Text] [Related]
16. Detection of Cell-Dissociated Non-Typeable
Thulborn SJ; Ceroni A; Haldar K; Mistry V; Cane JL; Brightling CE; Barer MR; Bafadhel M
Int J Chron Obstruct Pulmon Dis; 2020; 15():1357-1365. PubMed ID: 32606645
[TBL] [Abstract][Full Text] [Related]
17. The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable
Su YC; Jalalvand F; Thegerström J; Riesbeck K
Front Immunol; 2018; 9():2530. PubMed ID: 30455693
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against the Majority Subunit (PilA) of the Type IV Pilus of Nontypeable Haemophilus influenzae Disperse Moraxella catarrhalis from a Dual-Species Biofilm.
Mokrzan EM; Novotny LA; Brockman KL; Bakaletz LO
mBio; 2018 Dec; 9(6):. PubMed ID: 30538189
[TBL] [Abstract][Full Text] [Related]
19. UspA2 is a cross-protective Moraxella catarrhalis vaccine antigen.
Ysebaert C; Castado C; Mortier MC; Rioux S; Feron C; Di Paolo E; Weynants V; Blais N; Devos N; Hermand P
Vaccine; 2021 Sep; 39(39):5641-5649. PubMed ID: 34446318
[TBL] [Abstract][Full Text] [Related]
20. The Role of Non-Typeable
Weeks JR; Staples KJ; Spalluto CM; Watson A; Wilkinson TMA
Front Cell Infect Microbiol; 2021; 11():720742. PubMed ID: 34422683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
